By Professor Nadine Ezard

Conference Presentations

Acheson L; Ezard N; Fletcher K; Clifford B; Steele M; Moses M; Siefried K, 2024, 'A heuristic for evaluating methamphetamine withdrawal treatment programs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Freestone J; Xiao BJ; Siefried K; Bourne A; Ezard N; Maher L; Stirling R; Degenhardt L; Varma R; Hammoud M, 2024, 'Exploring service experiences among gay and bisexual men seeking to reduce or abstain from chemsex', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Broadbent E; Siefried K; Ezard N; MacDonald H; Gobeil J; Clifford B, 2024, 'Implementing a national Prompt Response Network to improve health-led decision making and processes for emerging drugs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Knock E; Ezard N; Day R; Siefried K; Liknaitzky P; Ross M; Albert S; Brett J, 2024, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: A novel safety and feasibility trial', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Siefried K; Clifford B; Acheson L; Ezard N, 2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023

Hill P; Clifford B; Brown J; Dessauer P; Oh G; Lyons T; Herbert A; McKinnon G; Lamb M; Crawford S; Mason C; Siefried K; Ezard N, 2023, 'Strength in solidarity: Bringing together diverse local stakeholders to disseminate public drug information (presented on behalf of the Prompt Response Network)', presented at Harm Reduction International, Melbourne, Australia, 16 April 2023 - 19 April 2023, https://hr23.hri.global/programme/

Ezard N; Clifford B; Siefried K; Acheson L, 2022, 'Safety and tolerability of lisdexamfetamine for  methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Nguyen Q; Ezard N, 2019, 'An Australian clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Ezard N; Acheson LS; Siefried KJ; Leicester OM; Rodgers C; Malone V; Clifford B; Bruno R, 2019, 'Substance use sex index (SUSI): A new behaviour change assessment tool', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Leung S; Deacon R; Rivas G; Monds L; Cubitt T; Nielsen S; Larance B; Ezard N; Lintzeris N, 2014, 'CHANGES IN ALPRAZOLAM USE AND RELATED HARM AMONG OPIOID TREATMENT PROGRAM CLIENTS FOLLOWING ITS RESCHEDULING TO A SCHEDULE 8 MEDICATION'

Lucas C; Ezard N; Day R, 2013, 'SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page